Notes
Amendment
25 Nov 2022 -
Supplementary data table 4 diagnosis (Table S17.1): corrected age-standardised rates for 25–74 for 2018, 2019, and 2020.
Australian Institute of Health and Welfare (2021) National Cervical Screening Program monitoring report 2021, AIHW, Australian Government, accessed 27 September 2024. doi:10.25816/mz9j-9925
Australian Institute of Health and Welfare. (2021). National Cervical Screening Program monitoring report 2021. Canberra: AIHW. doi:10.25816/mz9j-9925
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2021. AIHW, 2021. doi:10.25816/mz9j-9925
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2021. Canberra: AIHW; 2021. doi:10.25816/mz9j-9925
Australian Institute of Health and Welfare 2021, National Cervical Screening Program monitoring report 2021, AIHW, Canberra. doi:10.25816/mz9j-9925
PDF | 1.6Mb
This is the third report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in December 2017. In 2018–2020, there were more than 3.8 million participants aged 25–74, and in 2020, 10% of all screening HPV tests performed were positive for HPV types that cause cervical cancer. Cervical cancer incidence and mortality remained low at 10 new cases and 2 deaths per 100,000 women, respectively.
More than 3.8 million cervical screening participants aged 25–74 in 2018–2020
179 women aged 25–74 died from cervical cancer in 2019
743 women aged 25–74 diagnosed with cervical cancer in 2017
Cervical screening test positivity 10% in 2020
25 Nov 2022 -
Supplementary data table 4 diagnosis (Table S17.1): corrected age-standardised rates for 25–74 for 2018, 2019, and 2020.